Stanford researchers have developed a novel representation learning model that improves data-driven learning by incorporating more relevant data relationships. This approach significantly enhances both model performance and inference accuracy.
Researchers in Prof. Crystal Mackall's laboratory at Stanford University are focused on translational research related to cancer immunotherapy, including basic T-cell function and tumor immunology.
Stanford scientists in Dr. Michael Lin's lab have established the use of B-cell reducing agents to improve an oncolytic virus (OV) therapy to rewire cancer signaling while limiting the production of antibodies against the virus in mouse studies.
Stanford researchers have developed flat, ultrathin (sub 100nm) optical elements based on high index nanostructures which can be alternatives to refractive optical elements such as gratings, lenses, and axicons.
Stanford researchers have developed a patented, wearable, haptic feedback device that provides position and velocity information on the limbs and torso by imparting rotational skin stretch.
Stanford researchers in the Vuckovic group have fabricated thin-film 4H crystal structure Silicon Carbide with excellent quantum and classical photonics properties.
Heart failure is a complex cardiovascular disease that affects 26 million people worldwide and is characterized by the inability of the heart to pump blood effectively, leading to a decline in its normal functions.
Stanford researchers have created an optimized stuffer sequence derived from the human BMP-10 3'UTR to enhance the packaging efficiency, productivity, and safety of recombinant adeno-associated virus (rAAV) vectors in gene therapy applications.
Researchers at Stanford have discovered a therapeutic strategy to overcome off-target red blood cell (RBC) toxicity associated with anti-CD47 antibody cancer therapies and possibly antibody-mediated autoimmune anemia and thrombocytopenia.
Stanford researchers have demonstrated clinical proof of concept that a real-time biofeedback system can reduce pain and slow joint degeneration in patients with movement disorders such as knee osteoarthritis.
Stanford researchers have developed a method of reducing pulmonary hypertension (PH) in mammals by targeting FHIT (Fragile Histidine Triad), a gene not previously linked to PH but consistently reduced in blood of patients with pulmonary arterial hypertension (PAH).
Stanford scientists have developed a platform that combines Raman spectroscopy, nanomaterials, and machine learning to rapidly identify bacteria in wastewater without chemical labels.